a developer of therapeutics to treat hepatitis and other infectious diseases, using human antibodies and synthetic chemicals
Industry Biotechnology
A.I.dvisor indicates that over the last year, XTLB has been closely correlated with LABFF. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if XTLB jumps, then LABFF could also see price increases.
| Ticker / NAME | Correlation To XTLB | 1D Price Change % | ||
|---|---|---|---|---|
| XTLB | 100% | N/A | ||
| LABFF - XTLB | 70% Closely correlated | N/A | ||
| SER - XTLB | 59% Loosely correlated | -3.66% | ||
| ENTBF - XTLB | 29% Poorly correlated | +6.52% | ||
| SOLTF - XTLB | 26% Poorly correlated | N/A | ||
| TOVX - XTLB | 26% Poorly correlated | -0.70% | ||
More | ||||
| Ticker / NAME | Correlation To XTLB | 1D Price Change % |
|---|---|---|
| XTLB | 100% | N/A |
| middle east theme (69 stocks) | 16% Poorly correlated | -0.72% |
| diseases theme (41 stocks) | 7% Poorly correlated | -1.18% |
| therapeutics theme (53 stocks) | 5% Poorly correlated | -2.44% |
| human theme (15 stocks) | 3% Poorly correlated | +1.86% |
| drugs theme (254 stocks) | 3% Poorly correlated | -1.72% |
More | ||